Abstract
Women with an inherited mutation in BRCA1 or BRCA2 have a lifetime risk of breast cancer that ap- proaches 80% [...]
Highlights
The latter group of women includes those with a strong family history of breast cancer but no BRCA mutation 4, those with a mutation in CHEK2 5,6, those in the highest category of mammographic density 7, and those with a past history of lobular carcinoma in situ or atypical hyperplasia 8,9
In the United Kingdom, the Family History Study was undertaken to estimate how much life expectancy might reasonably be gained by an offer of annual mammography to women at moderate risk 10
Annual mammography was offered for 4 years to 6710 women with a family history of breast cancer who were younger than 50 years of age, but who were negative for both BRCA mutations
Summary
The latter group of women includes those with a strong family history of breast cancer but no BRCA mutation 4, those with a mutation in CHEK2 5,6, those in the highest category of mammographic density 7, and those with a past history of lobular carcinoma in situ or atypical hyperplasia 8,9. In the United Kingdom, the Family History Study was undertaken to estimate how much life expectancy might reasonably be gained by an offer of annual mammography to women at moderate risk 10. Annual mammography was offered for 4 years to 6710 women with a family history of breast cancer who were younger than 50 years of age, but who were negative for both BRCA mutations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.